Gemmer Asset Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-120
| Closed | -$16K | – | 364 |
|
|
2022
Q1 | $16K | Buy |
120
+1
| +0.8% | +$139 | ﹤0.01% | 553 |
|
|
2021
Q4 | $21K | Hold |
119
| – | – | ﹤0.01% | 495 |
|
|
2021
Q3 | $17K | Hold |
119
| – | – | ﹤0.01% | 518 |
|
|
2021
Q2 | $16K | Buy |
119
+4
| +3% | +$524 | ﹤0.01% | 605 |
|
|
2021
Q1 | $15K | Buy |
115
+64
| +125% | +$7.89K | ﹤0.01% | 605 |
|
|
2020
Q4 | $6K | Sell |
51
-37
| -42% | -$4.51K | ﹤0.01% | 887 |
|
|
2020
Q3 | $10K | Hold |
88
| – | – | ﹤0.01% | 604 |
|
|
2020
Q2 | $10K | Hold |
88
| – | – | ﹤0.01% | 582 |
|
|
2020
Q1 | $7K | Hold |
88
| – | – | ﹤0.01% | 633 |
|
|
2019
Q4 | $9K | Hold |
88
| – | – | ﹤0.01% | 675 |
|
|
2019
Q3 | $9K | Hold |
88
| – | – | ﹤0.01% | 691 |
|
|
2019
Q2 | $9K | Hold |
88
| – | – | ﹤0.01% | 690 |
|
|
2019
Q1 | $8K | Hold |
88
| – | – | ﹤0.01% | 776 |
|
|
2018
Q4 | $7K | Sell |
88
-2
| -2% | -$188 | ﹤0.01% | 757 |
|
|
2018
Q3 | $10K | Hold |
90
| – | – | ﹤0.01% | 694 |
|
|
2018
Q2 | $10K | Hold |
90
| – | – | ﹤0.01% | 694 |
|
|
2018
Q1 | $9K | Buy |
90
+2
| +2% | +$205 | ﹤0.01% | 728 |
|
|
2017
Q4 | $9K | Hold |
88
| – | – | ﹤0.01% | 740 |
|
|
2017
Q3 | $8K | Hold |
88
| – | – | ﹤0.01% | 757 |
|
|
2017
Q2 | $10K | Hold |
88
| – | – | ﹤0.01% | 633 |
|
|
2017
Q1 | $9K | Hold |
88
| – | – | ﹤0.01% | 681 |
|
|
2016
Q4 | $8K | Hold |
88
| – | – | ﹤0.01% | 706 |
|
|
2016
Q3 | $7K | Hold |
88
| – | – | ﹤0.01% | 744 |
|
|
2016
Q2 | $7K | Hold |
88
| – | – | ﹤0.01% | 706 |
|
|
2016
Q1 | $6K | Sell |
88
-4
| -4% | -$268 | ﹤0.01% | 741 |
|
|
2015
Q4 | $7K | Buy |
92
+41
| +80% | +$2.76K | ﹤0.01% | 680 |
|
|
2015
Q3 | $3K | Sell |
51
-26
| -34% | -$1.82K | ﹤0.01% | 964 |
|
|
2015
Q2 | $6K | Hold |
77
| – | – | ﹤0.01% | 768 |
|
|
2015
Q1 | $6K | Buy |
77
+26
| +51% | +$1.86K | ﹤0.01% | 805 |
|
|
2014
Q4 | $3K | Hold |
51
| – | – | ﹤0.01% | 1020 |
|
|
2014
Q3 | $3K | Hold |
51
| – | – | ﹤0.01% | 1022 |
|
|
2014
Q2 | $3K | Hold |
51
| – | – | ﹤0.01% | 1054 |
|
|
2014
Q1 | $3K | Buy |
+51
| New | +$2.73K | ﹤0.01% | 1035 |
|
Other funds holding DGX
DSA
Gemmer Asset Management's DGX Position: Q2 2022 in Review
Gemmer Asset Management sold out of Quest Diagnostics (DGX) in Q2 2022, closing a stake of 120 shares — an estimated $16K sold.
Gemmer Asset Management first reported a position in DGX in Q1 2014 and held it in 33 quarters. The position peaked at $21K in Q4 2021. 850 funds tracked by Wall St. Rank hold DGX as of Q2 2022.
- Gemmer Asset Management reported no remaining Quest Diagnostics position as of Q2 2022 after selling out during the quarter.
- Gemmer Asset Management sold 120 Quest Diagnostics shares in Q2 2022, an estimated $16K.
- Gemmer Asset Management first reported a position in Quest Diagnostics in Q1 2014 and held it in 33 quarters.
- Gemmer Asset Management's Quest Diagnostics position peaked at $21K in Q4 2021.
- 850 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.
Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.